Presbia Coöperatief U.A. announced that it has received medical device registration approval in Israel for its solution for near vision loss. With this approval, the company said the Flexivue Microlens, a reversible treatment for presbyopia that eliminates dependence on reading glasses or contact lenses for seeing near objects, is now commercially available in more than 40 countries across Europe, Latin America and the Middle East. Presbia reported that it will be working with Dagesh Eyes, its medical device distributor in Israel, to promote the Flexivue Microlens, a 3 mm in diameter implantable lens, to ophthalmologists across the country.
For the original article press here